Diagnostics Firm BillionToOne Files for US IPO Despite Shutdown

BillionToOne Inc. filed for a US initial public offering, becoming the second notable health-care company to advance public listing plans despite the US government shutdown.

The Menlo Park, California-based company had a net loss of $4.23 million on revenue of $125.54 million in the six months ending June 30, compared with a net loss of $15.19 million on revenue of $69.09 million a year earlier, according to a Tuesday filing with the US Securities and Exchange Commission.

The company has a single molecule NGS platform that detects and precisely quantifies genetic targets with single-molecule sensitivity. The platform enables them to ...